News26/06/2024
Formation Bio announces Series D financing
Formation Bio, Inc. →Formation Bio announced [figure hidden] of Series D financing led by a16z, with Sanofi participating alongside existing investors including Sequoia, Thrive and Emerson Collective. New participants included SV Angel Growth and FPV Ventures. The company intended to use the capital for drug acquisitions and in-licensing, and expansion of its AI capabilities. Scott Kupor and Alfred Lin were to join the board. The announcement does not provide an exact valuation or individual investor amounts. Its rounded financing headline is separate from the later SEC offering snapshot.